Licorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects

Journal of Health Science

Volumn 52, Issue 6, 2006, Pages 672-683

  Tominaga, Yuji ^a   Mae, Tatsumasa ^a   Kitano, Mitsuaki ^a   Sakamoto, Yoshiro ^b   Ikematsu, Hideyuki ^c   Nakagawa, Kaku ^a  

^a KANEKA CORPORATION   (Japan)

^b Kamiitabashi Clinic   (Japan)

^c Hara Doi Hospital   (Japan)

Author keywords

Body fat; Body weight; Clinical trial; Dual energy X ray absorptiometry; Flavonoid; Licorice

Indexed keywords

FLAVANOID; GLYCYRRHIZA EXTRACT;

ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; GLYCYRRHIZA; HUMAN; MAJOR CLINICAL STUDY; OBESITY; RANDOMIZED CONTROLLED TRIAL;

GLYCYRRHIZA;

EID: 33845502037     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.52.672     Document Type: Article

References (32)

1. Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G. and Shaw, J. (2005) The metabolic syndrome: a global public health problem and a new definition. J. Atheroscler. Thromb., 12, 295-300.
2. Ford, E. S., Giles, W. H. and Dietz, W. H. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, J. Am. Med. Assoc., 287, 356-359.
3. Nagao, T., Komine, Y., Soga, S., Meguro, S., Hase, T., Tanaka, Y. and Tokimitsu, I. (2005) Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am. J. Clin. Nutr., 81, 122-129.
4. Nakagawa, K., Kishida, H., Arai, N., Nishiyama, T. and Mae, T. (2004) Licorice flavonoids suppress abdominal fat accumulation and increase in blood glucose level in obese diabetic KK-A(y) mice. Biol. Pharm. Bull., 27, 1775-1778.
5. Fuhrman, B., Buch, S., Vaya, J., Belinky, P. A., Coleman, R., Hayek, T. and Aviram, M. (1997) Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr., 66, 267-275.
6. Fuhrman, B., Volkova, N., Kaplan, M., Presser, D., Attias, J., Hayek, T. and Aviram, M. (2002) Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition, 18, 268-273.
7. Haraguchi, H., Yoshida, N., Ishikawa, H., Tamura, Y., Mizutani, K. and Kinoshita, T. (2000) Protection of mitochondrial functions against oxidative stresses by isoflavans from Glycyrrhiza glabra. J. Pharm. Pharmacol., 52, 219-223.
8. Rosenblat, M., Belinky, P., Vaya, J., Levy, R., Hayek, T., Coleman, R., Merchav, S. and Aviram, M. (1999) Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J. Biol. Chem., 274, 13790-13799.
9. Belinky, P. A., Aviram, M., Mahmood, S. and Vaya, J. (1998) Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radical Biol. Med., 24, 1419-1429.
10. Belinky, P. A., Aviram, M., Fuhrman, B., Rosenblat, M. and Vaya, J. (1998) The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis, 137, 49-61.
11. Vaya, J., Belinky, P. A. and Aviram, M. (1997) Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radical Biol. Med., 23, 302-313.
12. Fukai, T., Marumo, A., Kaitou, K., Kanda, T., Terada, S. and Nomura, T. (2002) Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci., 71, 1449-1463.
13. Fukai, T., Satoh, K., Nomura, T. and Sakagami, H. (2003) Antinephritis and radical scavenging activity of prenylflavonoids. Fitoterapia, 74, 720-724.
14. Ofir, R., Tamir, S., Khatib, S. and Vaya, J. (2003) Inhibition of serotonin re-uptake by licorice constituents. J. Mol. Neurosci., 20, 135-140.
15. Yokota, T., Nishio, H., Kubota, Y. and Mizoguchi, M. (1998) The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res., 11, 355-361.
16. Shibata, S. (2000) A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi, 120, 849-862.
17. Aoki, F., Nakagawa, K., Tanaka, A., Matsuzaki, K., Arai, N. and Mae, T. (2005) Determination of glabridin in human plasma by solid-phase extraction and LC-MS/MS. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 828, 70-74.
18. Erselcan, T., Candan, F., Saruhan, S. and Ayca, T. (2000) Comparison of body composition analysis methods in clinical routine. Ann. Nutr. Metab., 44, 243-248.
19. Albanese, C. V., Diessel, E. and Genant, H. K. (2003) Clinical applications of body composition measurements using DXA. J. Clin. Densitom., 6, 75-85.
20. Gordon, D. J., Hyde, J., Trost, D. C., Whaley, F. S., Hannan, P. J., Jacobs, D. R. and Ekelund, L. G. (1988) Cyclic seasonal variation in plasma lipid and lipoprotein levels: the Lipid Research Clinics Coronary Primary Prevention Trial Placebo Group. J. Clin. Epidemiol., 41, 679-689.
21. Ma, Y., Olendzki, B. C., Li, W., Hafner, A. R., Chiriboga, D., Hebert, J. R., Campbell, M., Sarnie, M. and Ockene, I. S. (2006) Seasonal variation in food intake, physical activity, and body weight in a predominantly overweight population. Eur. J. Clin. Nutr., 60, 519-528.
22. Kajimoto, O., Kajimoto, Y., Yabune, M., Nakamura, T., Kotani, K., Suzuki, Y., Nozawa, A., Nagata, K., Unno, T., Mitane/Sagesaka, Y., Kakuda, T. and Yoshikawa, T. (2005) Tea Catechins with a Galloyl Moiety Reduce Body Weight and Fat. J. Health Sci., 51, 161-171.
23. Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G. and Morton, S. C. (2005) Meta-analysis: pharmacologic treatment of obesity. Ann. Intern. Med., 142, 532-546.
24. Tong, P. C., Lee, Z. S., Sea, M. M., Chow, C. C., Ko, G. T., Chan, W. B., So, W. Y., Ma, R. C., Ozaki, R., Woo, J., Cockram, C. S. and Chan, J. C. (2002) The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch. Intern. Med., 162, 2428-2435.
25. Greenway, F. L., De Jonge, L., Blanchard, D., Frisard, M. and Smith, S. R. (2004) Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes. Res., 12, 1152-1157.
26. Malpuech-Brugere, C., Verboeket-Van De Venne, W. P., Mensink, R. P., Arnal, M. A., Morio, B., Brandolini, M., Saebo, A., Lassel, T. S., Chardigny, J. M., Sebedio, J. L. and Beaufrere, B. (2004) Effects of two conjugated linoleic Acid isomers on body fat mass in overweight humans. Obes. Res., 12, 591-598.
27. Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Mitsunaga, T., Hashimoto, F. and Kiso, Y. (2005) Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J. Agric. Food Chem., 53, 4593-4598.
28. Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O. and Rossner, S. (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet, 365, 1389-1397.
29. Murase, T., Nagasawa, A., Hase, T., Tokimitsu, I., Shimasaki, H. and Itakura, H. (2001) Dietary Tea Catechins Reduce Development of Obesity Accompanied with Gene Expression of Lipid-metabolizing Enzymes in Mice. J. Oleo Sci., 50, 711-715.
30. Kusano, G., Shibano, M., Watanabe, H. and Ozaki, K. (2003) Pharmaceutical botanical studies on some Glycyrrhiza species. Yakugaku Zasshi, 123, 619-631.
31. Stormer, F. C., Reistad, R. and Alexander, J. (1993) Glycyrrhizic acid in liquorice - evaluation of health hazard. Food Chem. Toxicol., 31, 303-312.
32. Van Gelderen, C. E., Bijlsma, J. A., Van Dokkum, W. and Savelkoul, T. J. (2000) Glycyrrhizic acid: the assessment of a no effect level. Hum. Exp. Toxicol., 19, 434-439.